We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEM icon
751
Agnico Eagle Mines
AEM
$72.2B
$609K ﹤0.01%
11,725
-125
-1% -$5.9K
WRK
752
DELISTED
WestRock Company
WRK
$603K ﹤0.01%
17,151
-3,820
-18% -$133K
RGEN icon
753
Repligen
RGEN
$6.91B
$602K ﹤0.01%
+3,555
New +$645K
BURL icon
754
Burlington
BURL
$23.4B
$600K ﹤0.01%
2,960
-740
-20% -$118K
ETR icon
755
Entergy
ETR
$50.3B
$599K ﹤0.01%
10,652
+194
+2% +$10.6K
DISH
756
DELISTED
DISH Network Corp.
DISH
$597K ﹤0.01%
42,535
-16,526
-28% -$244K
EXAS
757
DELISTED
Exact Sciences
EXAS
$591K ﹤0.01%
11,935
-114,324
-91% -$4.67M
WOLF icon
758
Wolfspeed
WOLF
$1.04B
$578K ﹤0.01%
+8,377
New +$743K
FFIV icon
759
F5
FFIV
$22B
$576K ﹤0.01%
4,017
-959
-19% -$140K
LNC icon
760
Lincoln National
LNC
$7.92B
$573K ﹤0.01%
18,659
-9,598
-34% -$381K
WBS icon
761
Webster Financial
WBS
$12.3B
$561K ﹤0.01%
11,859
-2,796
-19% -$140K
DRI icon
762
Darden Restaurants
DRI
$24.3B
$552K ﹤0.01%
3,994
– –
NTES icon
763
NetEase
NTES
$83B
$552K ﹤0.01%
+7,600
New +$517K
AA icon
764
Alcoa
AA
$11.3B
$552K ﹤0.01%
12,135
-3,043
-20% -$132K
LSXMA
765
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$547K ﹤0.01%
18,927
-11,038
-37% -$336K
CTIC
766
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$541K ﹤0.01%
+90,000
New +$491K
OTEX icon
767
Open Text
OTEX
$6.28B
$539K ﹤0.01%
18,197
-4,060
-18% -$115K
BBWI icon
768
Bath & Body Works
BBWI
$3.97B
$526K ﹤0.01%
12,480
– –
RBA icon
769
RB Global
RBA
$21.5B
$524K ﹤0.01%
+9,074
New +$528K
DT icon
770
Dynatrace
DT
$12.7B
$520K ﹤0.01%
13,565
-2,957
-18% -$107K
MAT icon
771
Mattel
MAT
$4.47B
$518K ﹤0.01%
29,028
-545,261
-95% -$9.89M
ITUB icon
772
Itaú Unibanco
ITUB
$89.8B
$514K ﹤0.01%
123,642
-17,350
-12% -$78.8K
MASI
773
DELISTED
Masimo
MASI
$498K ﹤0.01%
3,366
-973
-22% -$134K
FTS icon
774
Fortis
FTS
$29.3B
$498K ﹤0.01%
12,449
– –
LEA icon
775
Lear
LEA
$7.39B
$497K ﹤0.01%
4,004
-915
-19% -$121K
29 30
31
32 33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.